Login / Signup

Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and Exacerbations.

Haiyang SuYuanlin SongShouzhi YangZiyue ZhangYao ShenLan YuShujing ChenLei GaoCuicui ChenDongni HouXinping WeiXuedong MaPengyu HuangDejun SunChunxue BaiKun Qian
Published in: ACS central science (2024)
Accurate diagnosis of chronic obstructive pulmonary disease (COPD) and exacerbations by metabolic biomarkers enables individualized treatment. Advanced metabolic detection platforms rely on designed materials. Here, we design mesoporous PdPt alloys to characterize metabolic fingerprints for diagnosing COPD and exacerbations. As a result, the optimized PdPt alloys enable the acquisition of metabolic fingerprints within seconds, requiring only 0.5 μL of native plasma by laser desorption/ionization mass spectrometry owing to the enhanced electric field, photothermal conversion, and photocurrent response. Machine learning decodes metabolic profiles acquired from 431 individuals, achieving a precise diagnosis of COPD with an area under the curve (AUC) of 0.904 and an accurate distinction between stable COPD and acute exacerbations of COPD (AECOPD) with an AUC of 0.951. Notably, eight metabolic biomarkers identified accurately discriminate AECOPD from stable COPD while providing valuable information on disease progress. Our platform will offer an advanced nanoplatform for the management of COPD, complementing standard clinical techniques.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • cystic fibrosis
  • machine learning
  • mass spectrometry
  • deep learning
  • drug delivery
  • intensive care unit
  • social media
  • quantum dots